Cytokinetics Inc. (cytk 3.5 07/01/27)
13F holders, Q1 2024 (March 31)7holders
$2.89avg. 13F price*
At the end of Q1 2024, 7 institutions reported holding Cytokinetics Inc. (cytk 3.5 07/01/27) in their 13F filings. The largest holders were Boussard & Gavaudan Investment Management LLP ($10.3M), Jane Street Group, LLC ($8.6M) and Lord, Abbett & Co. LLC ($2.5M).
- Company
- Cytokinetics Inc. (cytk 3.5 07/01/27)
- CUSIP
- 23282WAC4
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $13.3M |
| Exits | 1 | $19K |
Ownership 7 holders
| Boussard & Gavaudan Investment Management LLP | 1.87% | New | 6,351 | $10.3M |
| Jane Street Group, LLC | 0.01% | Reduce -49.1% | 5,397,000 | $8.6M |
| Lord, Abbett & Co. LLC | 0.01% | Reduce -78.0% | 1,564,000 | $2.5M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | New | 1,500,000 | $2.4M |
| Natixis | 0.00% | New | 399 | $640K |
| Nomura Holdings Inc. | 0.00% | No change | 5,745 | $403K |
| Bank of New York Mellon Corp | 0.00% | Reduce -50.0% | 200,000 | $317K |
"% of holder's portfolio" is CYTOKINETICS INC (CYTK 3.5 07/01/27)'s weight in each manager's 13F, not the share of Cytokinetics Inc. (cytk 3.5 07/01/27) the manager owns.